WellPoint (NYSE:ANTM) price target raised to $317.00 by Barclays

ME Staff
-
0

Analyst Ratings For WellPoint (NYSE:ANTM)

Today, Barclays raised its price target on WellPoint (NYSE:ANTM) to $317.00 per share.

There are 14 Buy Ratings, 2 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on WellPoint (NYSE:ANTM) is Buy with a consensus target price of $325.2680 per share, a potential 28.39% upside.

Some recent analyst ratings include

  • 4/23/2019-WellPoint (NYSE:ANTM) has coverage initiated with a Buy rating and $294.00 price target
  • 4/21/2019-WellPoint (NYSE:ANTM) had its Buy rating reiterated by Cantor Fitzgerald with a $360.00 price target
  • On 3/4/2019 Gloria M Mccarthy, EVP, sold 7,701 with an average share price of $303.73 per share and the total transaction amounting to $2,339,024.73.
  • On 2/4/2019 Gloria M Mccarthy, EVP, sold 7,700 with an average share price of $302.98 per share and the total transaction amounting to $2,332,946.00.
  • On 1/31/2019 Julie A Hill, Director, sold 500 with an average share price of $299.75 per share and the total transaction amounting to $149,875.00.
  • On 1/18/2019 Gloria M Mccarthy, EVP, sold 7,700 with an average share price of $265.00 per share and the total transaction amounting to $2,040,500.00.
  • On 12/27/2018 Peter D Haytaian, EVP, sold 3,000 with an average share price of $256.31 per share and the total transaction amounting to $768,930.00.
  • On 11/27/2018 Peter D Haytaian, EVP, sold 4,500 with an average share price of $278.48 per share and the total transaction amounting to $1,253,160.00.
  • On 11/8/2018 Julie A Hill, Director, sold 500 with an average share price of $287.25 per share and the total transaction amounting to $143,625.00.

About WellPoint (NYSE:ANTM)
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2018, it served 40 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Recent Trading Activity for WellPoint (NYSE:ANTM)
Shares of WellPoint closed the previous trading session at 253,42 up +2,23 0,89 % with 255.73 shares trading hands.